Literature DB >> 8027396

Cytological screening and management of abnormalities in prevention of cervical cancer: an overview with stochastic modelling.

C Sherlaw-Johnson1, S Gallivan, D Jenkins, M H Jones.   

Abstract

AIMS: To develop a mathematical model of the histological changes of precancer and the development of invasive cancer and how these are related to cytological findings. To use this to investigate the effects on incidence of cervical cancer, number of smear tests and colposcopies, of different schedules for cervical screening, and the clinical management policies for dyskaryosis.
METHODS: A stochastic model was developed relating the available data on tissue progression to the cytological findings. Two strategies, A and B, were compared: under A, women with any abnormal smear receive immediate colposcopy and treatment; under B, women with mild or borderline dyskaryosis have repeated smears at six monthly intervals with colposcopy only for persistent abnormalities.
RESULTS: The model predicted an incidence of invasive cervical cancer in an unscreened population of women aged over 18 years of 5.9 per 10,000 per year. With 70% coverage and three yearly screening under strategy A, the incidence fell to 2.00 and under B to 2.10. The number of smears required was similar but A required two to three times as many colposcopies as B. Raising the coverage to 90% reduced the incidence to around 1 per 10,000 per year but changing the screening interval, the specificity or sensitivity of cytology had much less effect.
CONCLUSION: The model has been tested under a wide range of possible variations in natural history, specificity and sensitivity of cytology. For low grade smear abnormalities, open colposcopic referral is predicted to reduce invasive cancer only slightly more than repeat cytology, at the expense of much additional colposcopy. Improving cytological coverage is suggested as more effective in reducing invasive cancer than increased use of colposcopy or more frequent screening.

Entities:  

Mesh:

Year:  1994        PMID: 8027396      PMCID: PMC502020          DOI: 10.1136/jcp.47.5.430

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  Management of squamous atypia (borderline nuclear abnormalities): repeat cytology or colposcopy?

Authors:  S K Tay; D Jenkins; A Singer
Journal:  Aust N Z J Obstet Gynaecol       Date:  1987-05       Impact factor: 2.100

2.  Cervical smears: new terminology and new demands.

Authors:  H Fox
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-23

3.  Terminology in gynaecological cytopathology: report of the Working Party of the British Society for Clinical Cytology.

Authors:  D M Evans; E A Hudson; C L Brown; M M Boddington; H E Hughes; E F Mackenzie; T Marshall
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

4.  A follow-up study of patients with cervical dysplasia.

Authors:  R M Richart; B A Barron
Journal:  Am J Obstet Gynecol       Date:  1969-10-01       Impact factor: 8.661

5.  Colposcopic assessment of the accuracy of cervical cytology screening.

Authors:  J A Giles; E Hudson; J Crow; D Williams; P Walker
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-16

6.  CIN 3: the role of lesion size in invasion.

Authors:  P Tidbury; A Singer; D Jenkins
Journal:  Br J Obstet Gynaecol       Date:  1992-07

7.  The invasive potential of carcinoma in situ of the cervix.

Authors:  W A McIndoe; M R McLean; R W Jones; P R Mullins
Journal:  Obstet Gynecol       Date:  1984-10       Impact factor: 7.661

8.  Should patients with mild atypia in a cervical smear be referred for colposcopy?

Authors:  W P Soutter; S Wisdom; A K Brough; J M Monaghan
Journal:  Br J Obstet Gynaecol       Date:  1986-01

9.  Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study.

Authors:  M J Campion; D J McCance; J Cuzick; A Singer
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

10.  A computer simulation model for the practical planning of cervical cancer screening programmes.

Authors:  D M Parkin
Journal:  Br J Cancer       Date:  1985-04       Impact factor: 7.640

View more
  6 in total

1.  Challenging the role of calibration, validation and sensitivity analysis in relation to models of health care processes.

Authors:  Steve Gallivan
Journal:  Health Care Manag Sci       Date:  2008-06

2.  Withdrawing low risk women from cervical screening programmes: mathematical modelling study.

Authors:  C Sherlaw-Johnson; S Gallivan; D Jenkins
Journal:  BMJ       Date:  1999-02-06

Review 3.  Cost-effective policies for cervical cancer screening. An international review.

Authors:  M C Fahs; S B Plichta; J S Mandelblatt
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

4.  Management of cervical dyskaryosis. Regular follow up is the key.

Authors:  D Jenkins; S Gallivan
Journal:  BMJ       Date:  1994-07-23

5.  Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK.

Authors:  M Kohli; N Ferko; A Martin; E L Franco; D Jenkins; S Gallivan; C Sherlaw-Johnson; M Drummond
Journal:  Br J Cancer       Date:  2006-12-05       Impact factor: 7.640

6.  The predicted effect of changes in cervical screening practice in the UK: results from a modelling study.

Authors:  K Canfell; R Barnabas; J Patnick; V Beral
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.